Showing results (91-100 of 1,479) with videos related to
Sort By:
Pageof 148
Human Psychopharmacology|October 31, 2002
Ritanserin as add-on medication to neuroleptic therapy for patients with chronic or subchronic schizophreniaJ. A. Den Boer, J.-O. Vahlne, P. Post, et al.Human Psychopharmacology|October 31, 2002
The interaction between cytokines and neurotransmitters in depression and stress: possible mechanism of antidepressant treatmentsCai SongHuman Psychopharmacology|October 31, 2002
Effect of NMDA receptor antagonist on naloxone-precipitated withdrawal signs in cholestatic miceAhmad Reza Dehpour, Morteza Samini, Hossein Rastegar, et al.Human Psychopharmacology|October 31, 2002
Extrapyramidal symptoms and residual psychopathology with low-dose neurolepticsDomenico Berardi, Annalisa Giannelli, Roberto Biscione, et al.Human Psychopharmacology|October 31, 2002
Comparison of simultaneous administration of lithium with L-NAME or L-arginine on morphine withdrawal syndrome in miceA. R. Dehpour, S. Sh. Sadr, M. Nouroddini, et al.Human Psychopharmacology|October 31, 2002
Comparison of the effect of levodopa and bromocriptine on naloxone-precipitated morphine withdrawal symptoms in miceMorteza Samini, Rashin Fakhrian, Massoud Mohagheghi, et al.Human Psychopharmacology|October 31, 2002
Prospective memory, everyday cognitive failure and central executive function in recreational users of EcstasyT. M. Heffernan, H. Jarvis, J. Rodgers, et al.Human Psychopharmacology|October 31, 2002
Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug historyK. Soar, J. J. D. Turner, A. C. ParrottHuman Psychopharmacology|October 31, 2002
A critical review of akathisia, and its possible association with suicidal behaviourLars HansenHuman Psychopharmacology|October 31, 2002
Mirtazapine and paroxetine: a drug-drug interaction study in healthy subjectsF. J. L. Ruwe, R. A. Smulders, H. J. Kleijn, et al.Pageof 148